| ||||||||||||||||||||||||
high quality evidence suggests vitamin d can reduce 1 attacks
a new cochrane review, published in the cochrane library today and presented at the ers international congress, has found evidence from randomised trials, that taking an oral vitamin d supplement in addition to standard asthma medication is likely to reduce severe asthma attacks. asthma is a common 2 disease affecting about 300 million people worldwide. the symptoms of asthma include 3, coughing, chest tightness and shortness of breath.
今天发表在cochrane图书馆并在ers国际大会上发表的一篇新的《cochrane评论》发现,随机试验的证据表明,除了标准哮喘药物外,口服维生素d补充剂可能会减少严重哮喘发作。哮喘是一种常见的慢性疾病,影响着全世界约3亿人。哮喘的症状包括喘息、咳嗽、胸闷和呼吸急促。
low blood levels of vitamin d have been linked to increased risk of asthma attacks in children and adults with asthma. there has been a growing interest in the potential role of vitamin d in asthma management because it might help to reduce upper respiratory infections, (such as the common cold) that can lead to exacerbations of asthma.
血液中维生素d水平低与哮喘儿童和成人哮喘发作风险增加有关。人们对维生素d在哮喘管理中的潜在作用越来越感兴趣,因为它可能有助于减少可能导致哮喘恶化的上呼吸道感染(如普通感冒)。
the researchers found that giving an oral vitamin d supplement reduced the risk of severe asthma attacks requiring hospital admission or emergency department attendance from 6% to around 3%.they also found that vitamin d supplementation reduced the rate of asthma attacks needing treatment with steroid tablets. these results are based largely on trials in adults. they also found that vitamin d did not improve lung function or day-to-day asthma symptoms, and that it did not increase the risk of side effects at the doses that were tested.
研究人员发现,口服维生素d补充剂可将需要住院或急诊的严重哮喘发作风险从6%降低到3%左右。他们还发现,补充维生素d可降低需要类固醇片治疗的哮喘发作率。这些结果主要基于对成年人的试验。他们还发现,维生素d不会改善肺功能或日常哮喘症状,在测试剂量下也不会增加副作用的风险。
点击收听单词发音
|
||||||||||||||||||||||||
上一篇:羚羊将古老的非洲森林“吃”成了草原 下一篇:酒精依赖症患者缺乏重要的酶 |
- 发表评论
-
- 最新评论 进入详细评论页>>